ABCG2 and myeloid leukemia: It is important to note that piceatannol appeared to be able to effectively eliminate BCRP-positive leukemia cells of two types, i.e., MOLT-4 human lymphoblastic leukemia cells [59] and HL-60 human myeloid leukemia cells.